Basic Information
| LncRNA/CircRNA Name | LINC00520 |
| Synonyms | NA |
| Region | GRCh38_14:55781135-55796688 |
| Ensemble | ENSG00000258791 |
| Refseq | NR_026796 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | qRT-PCR |
| Sample | BC blood |
| Expression Pattern | up-regulated |
| Function Description | The genetic variant of LINC00520 was related to the susceptibility of BC, and rs12880540 might affect the corresponding mRNA expression of lncRNA LINC00520. |
| Pubmed ID | 31997582 |
| Year | 2020 |
| Title | Characterization of lncRNA LINC00520 and functional polymorphisms associated with breast cancer susceptibility in Chinese Han population |
External Links
| Links for LINC00520 | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |